R. Terkeltaub
Rheumatology · 2002–2014
A researcher in the Science corpus: 5 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Rheumatology — 9 citations into it
Whom R. Terkeltaub trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- S. Goldring (in Rheumatology)
Papers from R. Terkeltaub's perspective
Ordered by how strongly the researchers R. Terkeltaub trusts endorse each paper. Same corpus, a different order for every researcher.
- A pilot study of IL-1 inhibition by anakinra in acute gout (Arthritis Research & Therapy)
- The Metabolic and Molecular Bases of Inherited Disease
- Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. (Arthritis & Rheumatism)
- EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT) (Annals of the Rheumatic Diseases)
- Febuxostat Compared with Allopurinol in Patients With Hyperuricemia and Gout
- The Role of Synovitis in Osteoarthritis pathogenesis (Bone)
- Comparison of Drug Adherence Rates Among Patients with Seven Different Medical Conditions (Pharmacotherapy)
- Synovial tissue inflammation in early and late osteoarthritis (Annals of the Rheumatic Diseases)
- Gout-associated uric acid crystals activate the NALP3 inflammasome (Nature)
- Toll-like receptor signalling (Nature reviews. Immunology)
Their papers
- Emerging regulators of the inflammatory process in osteoarthritis (2014) — 615 citations
- 2012 American College of Rheumatology Guidelines for Management of Gout Part I: Systematic Non-pharmacologic and Pharmacologic Therapeutic Approaches to Hyperuricemia (2012) — 1,532 citations
- 2012 American College of Rheumatology Guidelines for Management of Gout Part II: Therapy and Anti-inflammatory Prophylaxis of Acute Gouty Arthritis (2012) — 612 citations
- Mutations in ENPP1 are associated with 'idiopathic' infantile arterial calcification (2003) — 615 citations
- Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization (2002) — 851 citations